These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 788758)

  • 21. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to once-a-day Visken dosage.
    Bjerle P
    Med J Aust; 1977 Sep; 2(SP2):15-9. PubMed ID: 337072
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
    Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
    Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
    Lancaster R; Goodwin TJ; Peart WS
    Br J Clin Pharmacol; 1976 Jun; 3(3):453-60. PubMed ID: 973972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and renin during treatment with pindolol.
    Fyhrquist F; Kurppa K; Huuskonen M; Koistinen A
    Acta Med Scand; 1977; 202(1-2):55-60. PubMed ID: 899884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pindolol once daily in the treatment of hypertension.
    Frithz G
    Ups J Med Sci; 1976; 81(3):151-4. PubMed ID: 797084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K
    Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension.
    Morgan TO
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S808-13. PubMed ID: 6084130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of essential hypertension with pindolol.
    Bloem TJ; Kerkhof JV
    Cardiology; 1978; 63(3):168-74. PubMed ID: 346223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified antihypertensive therapy with pindolol retard.
    Kiowski W; Stumpe KO; Bühler FR
    Eur J Clin Pharmacol; 1982; 21(6):445-9. PubMed ID: 7075649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F; Heinze A; Werth HW
    Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.
    Stokes GS; Graham RM; Weber MA
    Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pindolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Golightly LK
    Pharmacotherapy; 1982; 2(3):134-47. PubMed ID: 6133267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
    Epstein SE; LUbbe WF
    S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 39. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 40. Pindolol in hypertension: twice-daily versus thrice-daily dosage.
    Waal-Manning HJ; Wood AJ
    Med J Aust; 1975 Aug; 2(7):274-5. PubMed ID: 1160793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.